Best Practice & Research in Clinical Rheumatology

Papers
(The TQCC of Best Practice & Research in Clinical Rheumatology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The importance of functional genomics studies in precision rheumatology103
Novel therapies – IMID Co-morbidities90
Update of imaging in the assessment of axial spondyloarthritis82
CAR T-cell therapy and indications for pediatric rheumatology82
Possible future avenues for myositis therapeutics: DM, IMNM and IBM62
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit48
Predicting and preventing clinical psoriatic arthritis47
Raynaud's phenomenon and digital ulceration in systemic sclerosis46
Novel therapies in Sjögren’s disease: A systematic review of the literature43
Rehabilitation interventions in osteoarthritis43
Epidemiology of rheumatic diseases in tropical populations40
Erratum to “Editorial Board” [Best Pract Res Clin Rheumatol (2025) 102094]38
Environmental factors and rheumatic diseases34
Novel therapies for axial spondyloarthritis and future directions34
Oral and maxillofacial manifestations of systemic sclerosis34
Rheumatic manifestations of HIV/AIDS28
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus28
The inequity of global healthcare in pediatric rheumatology27
Pathophysiology and immunolgical basis of axial spondyloarthritis27
Index for PART A26
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases25
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus24
Global epidemiology of psoriatic arthritis24
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis24
Genetics of osteoarthritis24
Diagnostic delay in axial spondylarthritis: A lost battle?23
Osteoporosis in 2022: Care gaps to screening and personalised medicine23
Decoding pain in axial spondyloarthritis: Mechanisms, management, and future directions23
The challenges in managing Psoriatic Arthritis in resource poor settings23
Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis?23
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights23
Editorial Board23
Genetics of rheumatoid arthritis23
CAR T cell therapy: Autoimmune neurological uses and neurotoxicities22
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps22
Preclinical RA: How to halt its progression22
Novel therapies and innovation for systemic sclerosis skin ulceration21
Patient-reported outcomes in vasculitis21
Index20
Editorial Board20
Where is bone science taking us?20
Pregnancy & neonatal outcomes in spondyloarthritis19
Editorial Board19
Imaging of crystal-induced arthropathies in 202519
Improving quality of care in systemic sclerosis19
Systemic lupus erythematosus19
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?19
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists19
The burden of osteoarthritis: Is it a rising problem?19
Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management18
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome18
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues18
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment18
Problems with “Problems with opioids beyond misuse”17
Malignancy and rheumatic diseases17
New and future therapies: Changes in the therapeutic armamentarium for SLE17
Imaging rheumatology: Emerging tools and expanding applications17
Infection associated Vasculitides16
Novel therapies in treatments of SLE16
CAR-T cell therapy for ANCA-associated vasculitis: Rationale, current evidence, and future directions16
Editorial Board15
Pregnancy in systemic lupus erythematosus14
Risk for osteoporosis and fracture with glucocorticoids14
Granzyme K+ CD8 T cells in autoimmunity14
Exercise in myositis: What is important, the prescription or the person?14
Editorial Board13
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances13
1.0211770534515